Home > JLRF Award
JLRF Award

JLRF Award

The 2016 Japan Leukemia Research Fund Awarding Ceremony was held on November 12, 2016 at the Incorporated Foundation, The Industry Club of Japan. The awards were given to 24 researchers and 1 group(NCCHD) this year.

[Ogimura Takashi Special Prize]
Ken-ichiro Seino (Division of Immunobiology, Institute for Genetic Medicine Hokkaido University)
“A critical role of IL-34 in multiple myeloma and its clinical application”

[Shimizu Award]
Hitoshi Kiyoi (Department of Hematology and Oncology, Nagoya University Graduate School of Medicine)
“Establishment of biomarker and suitable combination therapy for the novel irreversible-binding type FLT3 inhibitor by PDX model and comprehensive genetic analysis”

[Credit Saison Award]
Kanji Sugita (Department of Pediatrics, Graduate School of Medicine, University of Yamanashi)
“Development of novel therapy using lenalidomide and tyrosine kinase inhibitor for Philadelphia chromosome- positive acute lymphoblastic leukemia in children”

[Special Award --- Clinical Medicine Special Award ]
Yoichi Tanaka (Department of Clinical Pharmacy, Kitasato University School of Pharmacy)
“Evaluation of association between genetic factors and drug sensitivity in therapy for childhood acute lymphoblastic leukemia”

Hiroo Katsuya (Imperial Collage London/Center for AIDS Research, Kumamoto University)
“Detection of minimal residual disease in adult T-cell leukemia/lymphoma”

Takao Deguchi (Department of Pediatrics, Mie University Hospital)
“Clinical application of flowcytometric minimal residual disease in childhood acute lymphoblastic leukemia”

[General Research Award] (In no particular order)

Yosuke Masamoto (Department of Transfusion Medicine, The University of Tokyo Hospital)
“Development of novel targeted therapy for chronic myeloid leukemia using patient-derived induced pluripotent stemcells”

Daisuke Tomizawa (Children’s Cancer Center, National Center for Child Health and Development)
“Development of novel therapy with dimethylating agent azacitidine for infants with refractory/relapsed acute lymphoblastic leukemia”

Jiro Kikuchi (Division of Stem Cell Regulation, Center for Molecular Medicine, Jichi Medical University)
“Development of epigenetic therapy for pediatric leukemia with central nervous system infiltration”

Shinich Kako (Division of Hematology, Saitama Medical Center, Jichi Medical University)
“An optimal selection of treatment based on the identification of HLA haplotype in tumor cells, after relapse following allogeneic hematopoietic stem cell transplantation from a haploidentical donor for hematological malignancy”

Marito Araki (Juntendo University Graduate School of Medicine)
“Understanding of molecular mechanism of cytokine receptor activation by mutant CALR”

Natsuko Chiba (Department of Cancer Biology, Institute of Development, Aging and Cancer, Tohoku University)
“Carcinogenesis of Hematological Cancer by Abnormal Centrosome”

Yasushi Kubota (Department of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University)
“New therapeutic strategy for targeting intracellular cholesterol to eradicate leukemia stem cells”

Kazuhiko Kakihana (Hematology Division, Tokyo Metropolitan Komagome Hospital)
“Impact of gut microbiota on acute graft-versus host disease (GVHD) of the gut, and fecal microbiota transplantation for steroid refractory acute GVHD of the gut”

Tomoko Yokosuka (Hemato-oncology/Regenerative Medicine, Kanagawa Children’s Medical Center)
“Establishment of pharmacokinetics and pharmacodynamics of asparaginase in patients with acute lymphoblastic leukemia”

Masayuki Iwasaki (International Research Center for Medical Sciences, Kumamoto University)
“Development of new therapeutic strategies for targeting leukemia stemcells in MLL-rearranged AML”

Syuzo Kaneko (Division of Molecular Modification and Cancer Biology, National Cancer Center)
“Long non-coding RNAs as targets for anti-cancer drug development: based on the model of Leukemia stemcell”

[Research award for young researchers---- Special Award]
Takahiro Aoki (Department of Pediatrics, Graduate School of Medicine, Chiba University)
“Adoptive NKT-cell transfer immunotherapy in leukemia”

[Research award for young researchers] (In no particular order)
Hiroki Mizuno (Department of Immunology and Cell Biology, Graduate School of Medicine, Osaka University)
“Analysis of leukemia cell movement on living bone marrow and search for novel drug target”

Akihiro Tamura (Department of Hematology and Oncology, Kobe Children’s Hospital)
“Involvement of patrolling monocyte in hematological disease”

Ken Morita (Department of Human Health Sciences, Graduate School of Medicine, Kyoto University)
“DPYSL2 plays a pivotal role in KLF4- mediated monocytic differentiation of acute myeloid leukemia cells”

Ai Nogami-Hara (School of Pharmacy, Shujitsu University)
“Control of L-Asparaginase-induced allergy for the successful treatment of acute lymphoblastic leukemia”

Sho Kubota (Kumamoto University, IRCMS)
“Deregulation of chromatin dynamics in leukemic stem cell and in search of therapeutic target for leukemia”

Asuka Hira (Laboratory of DNA damage signaling, Department of late effects studies, Radiation Biology Center, Kyoto University)
“Identification and analysis of compound deficiency in aldehyde catabolizing enzymes: Clarification of the pathogenesis of a novel congenital bone marrow failure syndrome”

[2016 The Legend Special Award for the Group]
National Center for Child Health and Development(NCCHD) lifetime cohort study group
“Development of NCCHD life time cohort and data collection from childhood cancer survivors”

Award Recipient List of 2013-15